USFDA raises concerns about Ranbaxy's Toansa plant

The US Food and Drug Administration has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories Ltd, the drugmaker said on Monday, sending its shares down to......

Exports to EU from Ranbaxy's two plants to remain suspended

Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing even as Indian authorities have withdrawn the certification of manufacturing standards from......

Ranbaxy may have to pay huge fine, again

Ranbaxy Laboratories, set to be merged with Sun Pharmaceutical Industries, might again have to pay a hefty penalty to the US authorities for alleged violations at its Toansa factory in Punjab. The......

Another big blow for Ranbaxy

Ranbaxy Laboratories will have to pay a Rs 242-crore (Rs 2.42 billion) fine to the US authorities due to violations found at its Active Pharmaceutical Ingredient manufacturing factory in Toansa,......